LSB
LakeShore Biopharma Co., Ltd · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website ysbiopharm.com
- Employees(FY) 773
- ISIN KYG9845F2080
Performance
-14.32%
1W
-53.41%
1M
-23.34%
3M
-60.76%
6M
-34.44%
YTD
-50.81%
1Y
Profile
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Technical Analysis of LSB 2024-10-17
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-10-07 20:30
- 2024-09-26 19:00
- 2024-09-09 20:00
- 2024-09-03 20:00
- 2024-08-14 20:30
- 2024-07-04 19:00
- 2024-05-23 19:30
- 2024-05-21 04:15
- 2024-05-07 04:20
- 2024-04-28 20:00
- 2024-04-21 21:10
- 2024-04-18 23:52
- 2024-04-18 19:00
- 2024-04-17 20:00
- 2024-04-15 20:00
- 2024-04-08 22:06
- 2024-04-08 20:00
- 2024-04-02 20:00
- 2024-03-04 19:00
- 2024-02-22 04:00
- 2024-02-17 15:30
/C O R R E C T I O N -- YS Biopharma Co., Ltd./(Yahoo Finance)
- 2024-02-16 07:20
- 2024-02-16 04:36
- 2024-02-13 19:00
- 2024-02-13 18:50
- 2024-02-11 19:50
- 2024-02-08 17:30
- 2024-02-08 05:10
- 2024-01-24 03:00
- 2024-01-22 09:51
Page 1 of 2
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.